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Thy1-YFP+  cells  allow  follow  up  of neuronal  birth  and  fates  during  embryo  development.
Thy1-YFP+  neural  stem  cells  allow  in  vitro  analyses  of  cells’  features  and  potential.
Thy1-YFP+  neural  stem  cells  are  a robust  tool  to  follow  cells  after  transplantation.
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To  analyse  events  following  transplantation  of  stem  cells in the  brain  robust  tools  for tracing  stem  cells  are
required.  Here  we took  advantage  of  the  mouse  strain  B6.Cg-Tg(Thy1-YFP)16Jrs/J  (Thy1  YFP-16),  where
yellow  ﬂuorescent  protein  (YFP)  is  under  control  of  the  promoter  of  Thy1  gene.  This allows  visualising
whole  neurons,  i.e. their  cell body,  axons  and  dendrites.  In this  work  ﬂuorescent  cells  were  followed
during  embryonic  development,  in  vitro differentiation,  and  after  transplantation  in  the healthy  and
stroke-affected  mouse  brain.  During  embryonic  development  Thy1-YFP  positive  cells  were  ﬁrst  observed
on E12.5  and subsequently  located  in  the prosencephalon,  rhombencephalon,  spinal  cord  and  peripheral
nerves.  Quantitative  analysis  by  RT-PCR  and  immunocytochemistry  revealed  that  Thy1-YFP  positive  cells
during  embryo  development  and  in  vitro  differentiation  were  expressing  nestin  and  SOX2  then  MAP2,
3-tubulin  and  NeuN.  Thy1-YFP  positive  cells  isolated  from  E14.5  represented  21.88  ±  053%  (SD) of  the
cultivated  neurons  and  this  remained  constant  along  in vitro  differentiation.  On  the  other  hand,  proportion
of Thy1-YFP  positive  cells  reached  50%  of  neurons  in  perinatal  and  one  month  old  mouse  brain.  Neural
stem  cells  isolated  from  Thy1  YFP-16  mouse  strain  transplanted  near  hippocampus  of  the  healthy  and
stroke-affected  brain  were  distinguishable  by  YFP  ﬂuorescence.  They  differentiated  into  mature  neurons
and were  detectable  even  14  weeks  after  transplantation,  the end  point  of  our experiment.  In conclusion,
stem  cells  originating  from  Thy1  YFP-16  mice  represent  an  outstanding  tool  to  monitor  neurogenesis
enabling  morphological  analyses  of  new  neurons  and their  projections,  in  particular  after  transplantation
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in  the brain.
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1. Introduction
Beneﬁcial effects of stem cells and stem cell-derived neurons
and glia after transplantation in the nervous tissue provide a strong
rationale for cell therapy strategies for brain repair. To get insight in
events following stem cells transplantation, including their migra-
tion, survival and differentiation, robust tools to trace stem cells are
required. Commercially available exogenous dyes fade after several
weeks and the signal dilutes [1,2]. On the other hand, majority of
mouse lines characterized by presence of ﬂuorescent proteins in
neurons do not allow visualization of all cell projections and the
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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ignal present in cells is not linked to the stage of their differenti-
tion [3]. Design of mouse expressing ﬂuorescent reporter, under
ontrol of neuron speciﬁc Thy1 gene promoter, offered the pos-
ibility to speciﬁcally trace all parts of neurons, including the cell
ody, axon and dendrites [4]. Thy1 is a highly conserved cell surface
rotein belonging to immunoglobulin superfamily. It was  ﬁrstly
iscovered in thymus, where it marks precursors of T lymphocytes
THYmocyte differentiation antigen 1) [5]. In addition, it has been
iscovered in ﬁbroblasts, endothelial cells, smooth muscles and
ome subsets of neurons. Based on its involvement in cell–cell and
ell-matrix interactions, it is linked to cell and apoptotic signalling,
eukocyte adhesion, tumor suppression and ﬁbroblast proliferation
4–7]. Nevertheless since in B6.Cg-Tg(Thy1-YFP)16Jrs/J (Thy1 YFP-
6) yellow ﬂuorescent protein is expressed at high levels in a subset
f neurons [4,6,7] we hypothesized that ﬂuorescence depicting the
hole neuron can be used as a powerful tool to analyse differ-
ntiation of neural stem cells, in particular after transplantation.
resented study took systematic approach to achieve quantitative
escription of the ﬂuorescent cells obtained from Thy1 YFP-16 mice
uring neuronal differentiation both in vivo and in vitro. In addi-
ion, this study set a goal to compare cell fates in cell culture to
vents after the transplantation of cells into the brain of experi-
ental animals, as well as with the events that occur during normal
mbryonic development. Moreover, we could trace neural stem
ells transplanted in the healthy and stroke-affected mouse brain.
he analysis of birth and fates of neurons during embryonic devel-
pment, in vitro differentiation and after transplantation in the
ealthy and stroke-affected brain indicated that Thy1-YFP cells can
e used as a robust tool to monitor neural stem cells and to evaluate
heir differentiation by visualizing their growing projections.
. Materials and methods
.1. Animals and housing
Two mice strains have been used: B6.Cg-Tg(Thy1-YFP)16Jrs/J
Thy1 YFP-16) and C57Bl/6NCrl (wild type control) (The Jackson
aboratory, Bar Harbor, ME,  USA), kept on the same background.
he animals were kept at the animal facility at the Croatian Insti-
ute for Brain Research at the temperature 22 ± 2 ◦C, with 55% ± 10%
umidity, and 12/12 h light/dark cycle. Water and pelleted food
ere given ad libitum.  All experiments on animals described in
his work received approval of the Internal Review Board of the
thical Committee of the School of Medicine University of Zagreb
04-77/2010-238) and Faculty of Veterinary Medicine (251/61-
1/139-13-4) and they were carried out in accordance with the
U Directive 2010/63/EU on the protection of animals used for
cientiﬁc purposes.
.2. Neural stem cells and cell culture
For isolation of cells pregnant Thy1 YFP-16 females were sacri-
ced and neural stem cells were isolated from telencephalic wall of
14.5 fetuses using Accutase (Gibco by Life Technologies, A11105-
1). Isolated cells were placed into ﬂasks (BD Falcon, 353110) in a
peciﬁc proliferation supporting medium comprising of: DMEM/F-
2 (Gibco by Life Technologies, 31331-028), B-27 Supplement
Gibco by Life Technologies, 17504-044), N-2 Supplement (Gibco
y Life Technologies, 17502-048), Penicillin Streptomycin (Gibco
y Life Technologies, 15070-063), FGFb (Recombinant Mouse
ibroblast Growth Factor-basic, PMG0035) and EGF (Recombinant
ouse Epidermal Growth Factor, PMG8041). Cells were cultivated
n suspension, and after two days neurospheres were formed. For
he purpose of transplantation, neurospheres were dissociated by
ccutase and 1 million of cells were transplanted in 1 L of artiﬁ-ters 634 (2016) 32–41 33
cial CSF. For the purpose of differentiation analyses neurospheres
were dissociated, single cells and small neurospheres were plated
on 12 mm coverslips (200–250 000 cells per coverslip). Cover-
slips were previously coated with Poly-d-lysine (500 g/mL, 24 h
at 37 ◦C, SIGMA, P6407-5MG) and laminin (10 g/mL, 24 h at 37 ◦C,
SIGMA, L2020-1MG). Cells used for in vitro differentiation were
plated in a medium without proliferation factors. After 24 h the
medium was changed into: Neurobasal (Gibco by Life Technolo-
gies, 21103-049) which supports neurons in vitro and antibiotic
with glutamine (Pen Strep Glutamine, Gibco by Life Technologies,
10370-016). Cells were ﬁxed with 4% PFA (pH 7.4) on the 1st, 3rd,
5th and 7th day of differentiation.
2.3. RT-PCR
Total RNA was  isolated by using commercial RNeasy® Mini Kit
(Qiagen) following manufacturer instructions. After RNA isolation,
concentration was calculated on spectrophotometer (Nanodrop,
Thermoﬁsher Scientiﬁc) and by using high capacity RNA-to-cDNA
Kit (Applied Biosystems), RNA was  converted in cDNA. RT-PCR
was performed on cells in the same time points for three assays:
nestin (Mm00450205 m1), MAP2 (Mm00485231 m1)  and GFAP
(Mm01253033 m1). As housekeeping gene, we used -Actin (ACTB
MGB  4352933E) (TaqMan Gene Expression Assays). All samples
were made in triplicate with 1 g cDNA in total volume 20 L using
Applied Biosystems 7500 Real-Time PCR System. Relative quantiﬁ-
cation was  made using formula 2−CT.
2.4. Mouse stroke model by middle cerebral artery occlusion
(MCAO)
Ischaemic brain injury was  induced by transient left mid-
dle cerebral artery occlusion (MCAO) in wild type mice, age 3
months and weight 25–30 g. Operation was  performed in inhala-
tion anaesthesia, mixture 2% isoﬂurane in 100% O2. Surgery was
performed under dissection microscope (Zeiss, Stemi DV4 Spot).
During surgery animal body temperature was  maintained with
heating pad. Following ventral neck surgery and blood vessels
preparation, intraluminal ﬁlament (Doccol Company) was inserted
through common carotid artery (CCA) into internal carotid artery
(ICA) to the origin middle cerebral artery (MCA) and left 90 min.
After 90 min  intraluminal ﬁlament was withdrawn, perfusion was
restored and animal intraperitoneally received analgetic buprenor-
phine (0.03 mg/kg).
2.5. Stereotaxic transplantation of neural stem cells into the
mouse brain
Cells for transplantation into mouse brain were labelled with
PKH26 ﬂuorescent dye (PKH26GL-1KT, PKH26 Red Fluorescent Cell
Linker Kit for general cell membrane labelling, SIGMA, 081M0964)
following manufacturer’s instructions.
For stereotaxic transplantation we  used two groups of mice:
healthy and stroke-affected. In both groups animals were 3 months
old and weighted 25–30 g. Stereotaxic coordinates (AP −1.3, ML
+2.0 and DV −1.5) were determined according to stereotaxic atlas
[8] and injections were performed using KOPF stereotaxic appa-
ratus (900LS) and Hamilton syringe needle 1 L. For anaesthesia,
Avertin (Sigma, T48402-5G) was used at a dose of 0.5 g/kg, given
intraperitoneally. After transplantation animals were kept on the
heating pad and then they were returned to their cage.2.6. Animal sacriﬁce, perfusion, ﬁxation and tissue isolation
Wild type mice were anesthetized using Avertin (0.5 g/kg)
and then perfused transcardially with PBS and subsequently 4%
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Fig 1. Thy1-YFP expression at E14.5. Positive cells were observed in developing olfactory bulb (A), ponotomedullary part of rhombencephalon (B), ventral (C) and dorsal (D)
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corn  of the spinal cord. In peripheral nervous system positive cells were observed i
araformaldehyde in PBS (pH 7.4). Brains were isolated and fur-
her ﬁxed by immersion in the same ﬁxative at 4 ◦C overnight. They
ere washed in PBS and transferred to 10% sucrose followed by 30%
ucrose in PBS at 4 ◦C. Frontal 20 m thick sections were cut with
 cryostat and mounted on Superfrost Plus (Menzel Glaser) coated
lides.
Pregnant Thy1 YFP-16 females, at different stages of gestation
from 9th to 17th day) were used for embryo isolation. After sac-
iﬁce of pregnant animal, abdominal cavity was opened and the
mbryos were isolated by opening uterine wall and foetal mem-
ranes. Age of isolated embryos was conﬁrmed by checking outer
eatures speciﬁc for each stage, then ﬁxed in 4% PFA (pH 7.4) and
ryosectioned on 20 m thick slices as described above.
.7. Immunoﬂuorescence
Cells and tissues were immunolabelled with speciﬁc primary
ntibodies as followed: as stem cell markers – nestin (mouse mon-
clonal ab, diluted 1:200, Millipore, MAB353) and SOX2 (rabbit
olyclonal ab, diluted 1:200, Novus Biologicals, NB110-37235);
or neurons MAP2 (chicken polyclonal ab, diluted 1:1000, Abcam,
b5392), 3-tubulin (rabbit monoclonal ab, diluted 1:200, Cell Sig-
aling, D71G9) and NeuN (mouse monoclonal ab, diluted 1:200,
illipore, MAB377) and for astrocytes GFAP (chicken polyclonal ab,
iluted 1:250, Abcam, ab4674). Primary antibodies were diluted in
.2% Triton X-100 (Sigma. T8787-100ML) in PBS and 3% goat serum
t 4 ◦C overnight. Next day primary antibodies were rinsed in PBS
nd samples were further immunolabelled with ﬂuorescent sec-
ndary antibodies as followed: Alexa Fluor 546 goat anti-mouse
Invitrogen, A11003), Alexa Fluor 546 goat anti-rabbit (Invitrogen,
11010), Alexa Fluor 546 goat anti-chicken (Invitrogen, A11040)
nd Alexa Fluor 633 goat anti-rabbit (Invitrogen, A21070). Sec-
ndary antibodies were diluted 1:1000, except Alexa Fluor 633 goat
nti-rabbit (1:500) in 0.2% Triton X-100 in PBS. Secondary antibod-
es were rinsed with PBS and DAPI (Roche) was used as nuclear
ounterstain. Finally, cells and tissues were rinsed in PBS and
overslipped with Dako Fluorescent Mounting Medium (S3023).eloping spinal nerves (E) and in the cap stage of tooth (F).
Fluorescent analysis was made with confocal microscope Zeiss LSM
510 Meta.
2.8. Cell counting and quantiﬁcation
Number of positive cells was  counted on photographs obtained
by confocal microscope (Zeiss LSM 510 Meta) in ten ﬁelds per cov-
erslip in three independent experiments. For quantiﬁcation of cells
in vitro, days 0, 1, 3, 5 and 7 were analysed. Since Shapiro-Wilk test
revealed normal distribution of samples at different time-points
and ANOVA found no statistically signiﬁcant differences between
the time-point groups, we calculated average mean ± standard
deviation of both MAP2 and Thy1. As a limit of statistical signiﬁ-
cance P value < 0,01 was accepted. During embryonic development
we analysed stages from E12.5 to P0, neonates, 7 days and one
month old mice. Embryonic structures were determined and com-
pared with online atlas [9]. After we  deﬁned E17.5 as the referral
point, we counted cells in all regions of that embryo stage: “−”
refers to no signal, “+/−” to signal present in less than 10% of cells,
“+” to signal present in 10–20% of cells, “++” to signal present
in 20–35% of cells, “+++” to signal present in 35–50% of cells.
Other stages were compared to the referral point and evaluated
semi-quantitatively. The results were rated independently by two
evaluators and coincided 100%.
3. Results
3.1. Thy1-YFP cells allow follow up of birth and differentiation of
neurons during embryonic and early postnatal development
To analyse expression of Thy1 during embryonic and early post-
natal development we have analysed stages from E12.5 (onset of
Thy1 expression) to E17.5, then in neonates, 7 days and in one
month old mice (Fig. 1, Table 1). The ﬁrst Thy1-YFP positive cells
were observed on E12.5 in the central and peripheral nervous sys-
tem. In the central nervous system Thy1-YFP positive cells were
observed in the developing spinal cord, mostly in the future ventral
horns and some scattered cells in the developing brain (Fig. 2A–C).
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Table  1
Thy1-YFP expression during mice embryonic development. E17.5 has been deﬁned as the referral point and at that stage number of cells have been counted: “−” refers to
no  signal, “+/−” to signal present in less than 10% of cells, “ +” to signal present in 10–20% of cells, “++” to signal present in 20–35% of cells, “+++” to signal present in 35–50%
of  cells. Other stages were compared to the referral point and evaluated semiquantitatively. “PNS” peripheral nervous system, “E” embryonic day, “P” newborn, “W1” one
week  old pups, “M1” one month old mouse.
Neural system E12.5 E13.5 E14.5 E15.5 E16.5 E17.5 P0 W1 M1
CNS
Brain
Prosencephalon +/− +/− + + ++ ++ ++ +++ +++
Mesencephalon
Rhombencephalon + + ++ ++ +++ +++ +++ +++ +++
Spinal  cord
Ventral horn + ++ ++ +++ +++ +++ +++ +++ +++
Dorsal  horn +/− + + ++ +++ +++ +++ +++ +++
PNS
++
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n E13.5 number of Thy1-YFP positive cells increased in the ventral
orns, and to smaller extent in the dorsal horns of the spinal cord. In
he brain, positive cells were observed in the pontomedullary part
f rhombencephalon and some cells in olfactory bulbs (Table 1).
uring E14.5 number of Thy1-YFP positive cells was higher than
 day before (Fig. 2D–I, Table 1). Apart from already mentioned
tructures, positive cells were observed in the cranial and spinal
erves and in the developing tooth (Fig. 1). On E15.5 and E16.5
ositive cells exhibited morphology of mature neurons and the sig-
al present in cell extensions, including dendritic spines (Fig. 2J–L).
n E17.5, apart from described structures, Thy1-YFP positive cells
ere observed in retina. Also, on E17.5 Thy1-YFP positive cells were
bserved in CA1 region of hippocampus (Table 1).
To analyse types of cells detected by Thy1-YFP during embryo
evelopment, immunohistochemical staining was performed on
12.5, E14.5 and E16.5. While in vitro co-localization of nestin
nd Thy1-YFP was detected (see below), we  did not observe
uch co-localization in in vivo. In general, nestin positive cells
ere Thy1-YFP negative and they were mostly visible on E12.5
Fig. 2A–C) where they had a spindle-shaped morphology. With
ervous system maturation, number of nestin positive cells grad-
ally decreased. SOX2 positive cells were present in all three
xamined stages and they co-localized with Thy1-YFP (Fig. 2G–I).
AP2 (Fig. 2D–F and J–L) as well as 3-tubulin (not shown) were
lso positive and revealed co-localization with Thy1-YFP positive
ells.
In perinatal mouse (P0) THY1-YFP positive cells were observed
n the brain cortex and subventricular zone.
In one week old mouse brain Thy1-YFP positive cells were
resent in olfactory bulb (Fig. 3A), in the CA1 region of hippocampus
Fig. 3B) and in the brain cortex (Fig. 3C).
In one month old mouse, brain was completely developed and
ells extended a large number of their projections. Cells in olfactory
ulb were more branched than in one week old mouse (Fig. 3D),
n the hippocampus positive cells were present in CA1 and CA3
egion (Fig. 3E). In the cortex, 50% of Map2 and NeuN positive
eurons were Thy1-YFP positive (Fig. 3F). Furthermore, Thy1-YFP
ositive cells were present in thalamic nuclei. In the peripheral
ervous system, positive cells were present in retina and in all cra-
ial and spinal nerves including nerves of brachial and sacroiliac
lexus.
.2. Thy1-YFP cells allow follow up and detailed morphological
nalyses of differentiation of neural stem cells in vitroTo describe differentiation of Thy1-YFP positive cells and
ppearance of the signal in vitro we used neural stem cells cultures
btained from YFP-16. We  analysed the progress of differentiation ++ ++ ++ +++ +++
 ++ ++ ++ +++ +++
+ ++ +++ +++
on both RT-PCR and immunocytochemical level. Already during the
ﬁrst day of differentiation Thy1-YFP positive cells were present
in a form of rounded progenitor cells with lower ﬂuorescent sig-
nal and in a form of more mature cells with a bright ﬂuorescent
signal (Fig. 4A–C). RT-PCR analyses revealed that on day 0 expres-
sion of nestin was  the highest and there was  as well signal of
MAP2 present (Fig. 5C). Immunocytochemical analyses conﬁrmed
that scarce more mature cells were SOX2, MAP2, 3-tubulin and
NeuN positive but they were not nestin positive. Thy1-YFP pos-
itive progenitor cells exhibited co-localization with nestin. Both
Thy1-YFP positive progenitor and mature neurons were SOX2 pos-
itive (not shown). The percentage of cells co-expressing Thy1-YFP
and neuronal markers (MAP2, 3-tubulin) during the ﬁrst day of
differentiation was  22.5 ± 0.4% (Fig. 5A).
On the third day of differentiation RT-PCR analyses revealed
that expression of nestin dropped for 40% in comparison to day
0 and that expression of MAP2 doubled (Fig. 5B,C). Indeed, cell
morphology suggested progression toward more differentiated cell
types. Number of nestin positive cells in culture decreased from
99% to 30% while proportion of neuronal cells increased to 70%
when compared to the previous stage (Fig. 5B,C). On this stage
we detected some GFAP-expressing cells, although immunocyto-
chemistry was still not able to visualize them. The percentage
of cells co-expressing Thy1-YFP and neuronal markers (MAP2,
3-tubulin) on the third day of differentiation was 21.3 ± 0.5%
(Fig. 5A).
On the ﬁfth day of differentiation the decrease of expression of
nestin and increase of MAP2 continued. Cells positive for neuronal
markers appeared as mature and highly branched. The percent-
age of cells co-expressing Thy1-YFP and neuronal markers (MAP2,
3-tubulin) was  21.9 ± 0.5% (Fig. 5A). GFAP positive cells were
observed on day 5 as 1% of a total number cells/coverslip, which
was as well seen on RT-PCR on day 3 (Fig. 5B,C).
On the seventh day of differentiation majority of cells exhibited
morphology of fully differentiated neurons, although less than 7%
of cells remained rounded without projections and they were pos-
itive for nestin. Most of these branched cells were MAP2 (Fig. 4G–I)
and 3-tubulin positive and they co-localized with THY1-YPF cells
(Fig. 4E–H). The percentage of cells co-expressing THY1-YFP and
neuronal markers (MAP2, 3-tubulin) on the seventh day of differ-
entiation was 21.5 ± 0.6% (Fig. 5A). GFAP positive cells represented
3% of a total cell count, and as we expected, they did not co-localize
with THY1-YFP positive cells (Fig. 4J–L). Thus expression of Thy1-
YFP was  observed already in neural stem cells, it was present in
21.88 ± 0.53% of neurons during all stages of differentiation and
the signal was present in all parts of the cell.
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Fig. 2. Thy1-YFP expression during embryonic development. Immunohistochemical reaction against nestin did not reveal co-localization between nestin and Thy1-YFP at
E ction a
v 2 (J–L
3
a
i
r
T12.5  in the ventral horn of developing spinal cord (A–C). Immunohistochemical rea
entral horn of developing spinal cord. Immunohistochemical reaction against MAP
.3. Thy1-YFP cells are a robust tool to trace migration, survival
nd differentiation of stem cells after stereotaxic transplantation
n the mouse brainTo analyse to which extent differentiation of transplanted neu-
al stem cells will follow their biological pattern, PKH26 – labelled
hy1-YFP cells were transplanted near hippocampus of the wildgainst MAP2 (D–F) and SOX2 (G–I) revealed co-localization with Thy1-YFP at E14.5
) showed co-localization with Thy1-YFP at E16.5 developing hindbrain.
type and stroke-affected mice. Brains were isolated 2, 4, 8 and 14
weeks after transplantation.
In the healthy brain two weeks after transplantation cells were
present on the site of transplantation and we easily distinguished
transplanted cells from the host tissue. A great majority of trans-
planted cells were clearly PKH26 positive and they exhibited
morphology of small rounded cells. A small percentage of these
I. Alic´ et al. / Neuroscience Letters 634 (2016) 32–41 37
Fig. 3. Thy1-YFP expression in one week (A–C) and one month (D–F) old mouse: olfactory bulb (A and D), hippocampus (B and E) and cortex (C and F).
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wells were Thy1-YFP positive and these cells were among those ones
hich extended projections (Fig. 6A–C). In the stroke-affected brain
ome cells left the place of transplantation and migrated towards
he region affected by ischemia.
In the healthy brain four weeks after transplantation, cells
ere present on the site of transplantation and some of them
igrated down the corpus callosum. Number of Thy1-YFP pos-
tive cells was higher than two week after transplantation and
hose cells revealed more mature morphology (Fig. 6D–F). Because
he site of transplantation was near the lateral ventricle some
ells entered into ventricle. Those cells which entered ventricle
ormed spheres which contained more differentiated Thy1-YFP
ositive cells. Spheres were present in all ventricles, they attached
o ependymal cells and their dendrites incorporated into the host
issue. In the stroke-affected brain majority of cells left the place of
ransplantation and migrated towards the stroke affected region.
hey appeared as branched neurons and in general, their differen-
iation reached more mature stage than in healthy brain.
In the healthy brain eight weeks after transplantation intensity
f PKH26 dye decreased and only few cells were PKH26 cells posi-
ive. On the other hand, Thy1-YFP positive cells were easily visible
nd they were incorporated into the host tissue (Fig. 6G–I). The
ain difference between normal and stroke-affected brain was  that
n normal brain cells made clumps with lower amount of differenti-
ted cells. In the stroke affected brain, differentiated cells exhibited
orphology of mature, branched neurons which were completely
ncorporated into the host tissue.
Fourteen weeks after transplantation, PKH26 positive cells have
ot been detected into the host brain anymore. On the other
and Thy1-YFP positive cells were clearly visible and they revealed
ature phenotype. This was especially clear in the stroke affected
rain when they were branched and they connected mutually and
ith the host cells. Spines on transplanted cells were completelydeveloped and resembled those ones observed in in vitro differen-
tiated neurons (Fig. 6J–L).
4. Discussion
Stem cell based therapy holds great promise in ﬁnding effective
therapeutic strategies for brain diseases [10]. However, more data
and knowledge about events occurring after the cells are trans-
planted in the brain of the patient or experimental animal are
needed for follow-up and translation into clinical study. In spite
of substantially increased number of experiments based on stem
cell transplantation in the last decades, we  still lack a satisfactory
method to trace cells in a longer time span and to visualize all their
projections [3]. So far, any exogenous stain used, including PKH26,
which was  tested in this work, dilutes and loses its efﬁciency after
4–6 weeks. Similar problems have been already reported [1]. More-
over we  wanted to test to which extent development of cells with
ﬂuorescent signal in vitro can be compared to that one in in vivo.
Results of this study revealed precise pattern of Thy1-YFP
expression in vitro, during embryonic development and after
transplantation into the mouse brain. Although the exact rea-
son why  only portion of the cells express Thy1 and why  it is
present in all parts of the cells remains unknown, we  know that
Thy1 has widespread functions. They include: inhibition of neu-
rite outgrowth, apoptotic signalling, leukocyte and melanoma cell
adhesion and migration, tumor suppression and ﬁbroblast prolifer-
ation and migration [11]. Elevated Thy1 expression was described
at the site of inﬂammation, in the formation of the tumour stroma
and during tissue remodelling in the case of injuries [12]. Our
result that approx. 22% of cells express YFP in analysed line can
be explained with mosaicism inherent to this line. On the other
hand, this ratio of cells is perfect for precise visualization of all cell
processes. If this number would be higher, the signal would be too
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Fig. 4. Expression of Thy1-YFP during differentiation of neural stem cells in vitro: Immunocytochemical reaction against nestin on the 1st day of differentiation revealed that
Thy1-YFP positive cells in more differentiated stages do not colocalize with nestin, while some immature progenitors exhibit presence of both nestin and weak expression of
Thy1  (A–C). Immunocytochemical reaction against 3-tubulin on the 3rd day of differentiation revealed co-localization of Thy1 and 3-tubulin (D–F). Immunocytochemical
reaction against MAP2 (G–I) and GFAP (J–L) on the 7th day of differentiation revealed that cells were predominantly neurons, demonstrated with neuron speciﬁc markers
(MAP2 and 3-tubulin) and they co-localized with Thy1-YFP positive cells. GFAP positive cells did not exhibit co-localization with Thy1.
s
p
T
ntrong and many processes would be overlapping, thus reducing
ossibility to trace them precisely.
This work analysed the expression pattern of Thy1 in the strain
hy1 YFP-16. Although it was reported that during development,
euronal expression of Thy1 is low [12] and that undifferentiatedneurospheres were not YFP positive [13] in our study we were able
to recognize Thy1-YFP positive cells in progenitor cells as well as in
mature cells. Progenitor cells were Thy1 positive from the begin-
ning of stem cell isolation and they were nestin and SOX2 positive.
Although, Thy1-YFP positive cells, during ﬁrst ﬁve days were not
I. Alic´ et al. / Neuroscience Let
Fig. 5. Quantitative immunocytochemical (A and B) and RT-PCR (C) analysis of
differentiation markers in cell culture. A) Number of Thy1-YFP positive cells
during in vitro differentiation was constant, in the range 21.3–22.5% (average:
21.88 ± 0.53%). B) Number of nestin positive cells during in vitro differentiation
decreased from 99 to 7%, while number of cells which expressed neuronal mark-
ers  (MAP2 and 3-tubulin) was constantly increasing. GFAP positive cells were
observed on the 5th day of differentiation. C) RT-PCR conﬁrmed results of cell count-
ing.  The only difference was that on the 3rd day of differentiation we observed
expression of GFAP in a very small subset of cells, which appeared visible on
immunocytochemistry two  days later. Legend: X – days of differentiation and Y
–
R
m

o
t
e
o
s
A
o
p number of counted cells (A), percentage of counted cells (B) and percentage of
NA expression (C). Bars represent standard deviations.
ature neurons, they expressed typical neuronal markers (MAP2,
3-tubulin and NeuN) but retain SOX2 positivity.
During embryonic development Thy1-YFP positive cells were
bserved on E12.5 in the central and peripheral nervous sys-
em. This is different to Feng et al. [4] who reported that the
arliest expression was detectable in motor axons on E13. More-
ver, another publication described YPF expression on another, “H”
train and showed that Thy1-YFP expression begins after birth [14].
nother group which used the same “H” strain described YFP ﬂu-
rescence in cell bodies and axons in pyramidal neurons of the
ostnatal brain, while on E16 brain, they reported a weak expres-ters 634 (2016) 32–41 39
sion only in cell bodies [15]. In this study we described detailed
expression of Thy1-YFP during the whole differentiation and sub-
tle differences at various stages. This includes expression in some
parts not mentioned before, like in spinal and cranial nerves or in
developing teeth on the E14.5.
Complexity of the host nervous tissue and the process of dif-
ferentiation of the transplanted cells into mature neurons require
careful selection of the cell tracing strategy. The oldest and
still useful protocols include inter-special transplantations (e.g.
chicken-quail) or transplantations of male originated cells into
female hosts. Introduction of vital dyes or DNA and other cell trac-
ers which bind to certain cell elements (nucleus, cytoplasm or cell
membrane) [1,16] offers possibility to easily mark cells and follow
them in the limited time period before dyes dilute and cells become
phagocyted. Transgenic methods brought possibility to genetically
mark cells [4]. If the stable transfection is not possible, then it lasts
for limited amount of time. The stable transfections bring either
new cell lines or mouse strains with various cell parts and cell
subtypes marked.
Although the cell labelling with a speciﬁc dye is a relatively sim-
ple procedure, this approach has some drawbacks: cell divisions
decrease the signal intensity and death − phagocytosis of those cells
lead to occurrence of signal in surrounding host cells [1]. Our group
has been testing several types of exogenous dyes, including PKH26
(Sigma) or BrdU (Sigma) and all these methods are reliable but only
for short to mid-term tracing applications (up to 4 weeks). Since
ubiquitous ﬂuorescent marker − expressing transgenic strains fail
to mark all cell projections, which we  as well described in our own
works [3] here we suggest a use of Thy1-YFP strain for several
applications not been described so far: apart from analyses of neu-
ronal differentiation during embryo development, neural stem cells
isolated from this strain can be successfully used in in vitro experi-
ments, where this line offer possibility to visualize every single cell
projection, and in studies when long tracing of transplanted cells
with neuronal fate is needed. Reported fact that 21.88 ± 0.53% of
neurons obtained from this strain express Thy1-YFP is ideal ratio
for visualizing all processes, which is comparable to Golgi stain-
ing. Stability of the signal and even its increased presence in stroke,
which is similar to some already reported genes [17], conﬁrms high
applicability of this model. Moreover this strain has been recently
rediscovered by several groups suggesting application in some spe-
ciﬁc ﬁelds of interest: visualization of neuromuscular junction [18],
organotypic culture of retina [19] or even for visualizing experi-
mental tumours, inﬂammation and wound-healing [20].
5. Conclusions
Our results showed that, in addition to mature neurons, neu-
ronal progenitor cells express Thy1-YFP both in in vivo and in vitro
conditions. This suggests that in addition to analyses of neuronal
differentiation in Thy1 YFP-16 mouse, neural stem cells isolated
from this strain can be successfully used for long term tracing of
cells in which analyses of neuronal fate is needed. This has been
conﬁrmed in both healthy and stroke affected mouse brain.
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